Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System.
- Resource Type
- Academic Journal
- Authors
- Panebianco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy. valeria.panebianco@uniroma1.it.; Briganti A; Unit of Urology/Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.; Boellaard TN; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Catto J; Academic Urology Unit, University of Sheffield, Sheffield, UK.; Comperat E; Department of Pathology, Sorbonne University, Assistance Publique-Hôpitaux de Paris, Hopital Tenon, Paris, France.; Efstathiou J; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Giannarini G; Urology Unit, Academic Medical Centre 'Santa Maria della Misericordia', Udine, Italy.; Girometti R; Institute of Radiology, Academic Medical Centre 'Santa Maria della Misericordia', Udine, Italy.; Mertens L; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Amsterdam, The Netherlands.; Takeuchi M; Department of Radiology, Radiolonet Tokai, Nagoya, Japan.; Muglia VF; Department of Medical Images, Radiation Therapy and Oncohematology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.; Narumi Y; Department of Healthcare, Tachibana University, Kyoto, Japan.; Novara G; Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy.; Pecoraro M; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.; Roupret M; Department of Urology, Sorbonne University, AP-HP, Pitié Salpétrière Hospital, Paris, France.; Sanguedolce F; Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.; Santini D; Division of Medical Oncology A, Policlinico Umberto I, Rome, Italy.; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.; Shariat SF; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Simone G; IRCCS 'Regina Elena' National Cancer Institute, Department of Urology, Rome, Italy.; Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Woo S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Barentsz J; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The Netherlands.; Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Source
- Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500082 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4820 (Electronic) Linking ISSN: 17594812 NLM ISO Abbreviation: Nat Rev Urol Subsets: MEDLINE
- Subject
- Language
- English
Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.
(© 2023. Springer Nature Limited.)